Rivaroxaban plus aspirin in obese and overweight patients with vascular disease in the COMPASS trial.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Guzik TJ., Ramasundarahettige C., Pogosova N., Lopez-Jaramillo P., Dyal L., Berkowitz SD, Muehlhofer E., Bhatt DL., Fox KAA, Yusuf S, Eikelboom JWE:

Journal title: Journal of the American College of Cardiology,

Journal number: 07351097

Journal publisher: Elsevier BV

Published year: 2021

Published pages: 77(5), pp. 511-525.

DOI identifier: 10.1016/j.jacc.2020.11.061

ISSN: 0735-1097